Visit the below You Tube link to see this month's message and previous messages.
https://www.youtube.com/watch?v=6tL5EqPoPGI&index=1&list=PLIa1oelW_zJ-ah4F-3P_hL8G_mdIzSD4q
Professor Hywel Williams the Director of the NIHR HTA Programme writes a monthly Director’s Message. This month’s message includes Hywel’s tips on how to improve your research application by getting a review from outside of your team, and Hywel’s appreciation of NIHR.
Visit the below You Tube link to see this month's message and previous messages.
https://www.youtube.com/watch?v=6tL5EqPoPGI&index=1&list=PLIa1oelW_zJ-ah4F-3P_hL8G_mdIzSD4q
20 May 2022
To mark Clinical Trials Day we take a look at some of the recent developments at NDORMS and celebrate the teams that make this important area of our research programme possible.
29 April 2022
Injection of the anti-TNF drug adalimumab into Dupuytren’s disease nodules is effective in reducing nodule hardness and nodule size.
6 April 2022
A new study published in JAMA, has found that a drug recently licensed in the UK has no effect on post-operative knee replacement recovery or pain, compared to the current treatment when administered at site of surgery.
4 April 2022
10 February 2022
The White 5 trial compared implants fixed with bone cement against uncemented implants for hip fractures treated with hemiarthroplasty.
2 February 2022
FUTURE-GB has bounced into 2022 ahead of both predicted recruitment into Stage 2 (the Randomised Controlled Trial), and the sites open in Stage 2! Congratulations to all our sites for their hard work so far.